PMID: 7023313Sep 1, 1981Paper

The control of chemotherapy-induced emesis

Annals of Internal Medicine
L J Seigel, D L Longo

Abstract

Nausea and vomiting are frequent and serious toxicities of cancer chemotherapy that have been largely ignored in the past. Recently there has been renewed interest in this significant problem, with important advances in understanding the physiology of vomiting and a burgeoning number of clinical trials that use newer classes of antiemetics. At present phenothiazines are the only class of antiemetics that have shown both efficacy and safety in large numbers of cancer patients, but they are inadequate against strongly emetic agents such as cisplatin. New agents and new approaches have shown promise but need additional testing before they can be recommended for routine use.

Citations

Jan 1, 1985·European Journal of Clinical Pharmacology·R A JossK W Brunner
Feb 1, 1986·Journal of Behavioral Medicine·M A Andrykowski
Dec 1, 1982·Journal of Behavioral Medicine·D R Nicholas
Mar 9, 1995·Molecular and Cellular Biochemistry·E BabuD Sakthisekaran
Jul 15, 1983·Klinische Wochenschrift·H H GerhartzE Hiller
Nov 1, 1987·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·O U PetringH E Poulsen
Jan 1, 1986·Pharmacology, Biochemistry, and Behavior·L E SeylerK Parker
Jan 1, 1984·Molecular Aspects of Medicine·J H Barnes
Mar 1, 1984·Behavioural Brain Research·D O CarpenterN Strominger
Feb 18, 1982·The New England Journal of Medicine·C R Blagg
Jul 22, 1982·The New England Journal of Medicine
Dec 9, 1982·The New England Journal of Medicine·G R Morrow, C Morrell
Oct 24, 2003·International Anesthesiology Clinics·Paul F White
Dec 1, 1991·Journal of Clinical Pharmacy and Therapeutics·A J Freeman, M H Cullen
Mar 5, 1983·British Medical Journal·T SenskyK W Pettingale
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·H Lip
Jan 1, 1989·Drug Metabolism Reviews·P L CarlA H Rezvani
Mar 16, 2001·Expert Opinion on Pharmacotherapy·S M Walton
Jan 1, 1992·Cancer Investigation·K S SridharV Cairns
Jan 1, 1984·Cancer Investigation·J J Fiore, R J Gralla
Jan 1, 1988·Cancer Investigation·P L TriozziJ Laszlo
May 1, 1994·Mayo Clinic Proceedings·T A Rummans
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D CunninghamN Wells
Jul 1, 1997·Cancer Treatment Reviews·N I WeijlS Osanto
Nov 1, 1991·Journal of Pain and Symptom Management·N TsavarisP Kosmidis
Mar 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S KaasaL Carruthers
Mar 1, 1983·Cancer Treatment Reviews·F H LeeL Lenaz
Jun 1, 1985·Journal of Clinical and Hospital Pharmacy·L J Dodds
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S M Grunberg
Jun 1, 1996·American Journal of Obstetrics and Gynecology·M P NageotteT Asrat
Apr 15, 1988·Cancer·K S Sridhar, E Donnelly
Jul 1, 1987·The American Journal of Hospice Care·R E Enck, C M Hogan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.